ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,264.70
-0.20%
Dow Jones
44,722.06
0.00%
Gold vs US Dollar
2,659.135
0.77%
Brent Oil
72.94
0.36%
Bitcoin
96,994.31
1.40%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Oncology Pharma Inc (CE) (ONPH)

  7. Oncology Pharma Inc (CE) (ONPH) News

Oncology Pharma (CE) (ONPH)

Oncology Pharma Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ONPH
DateTimeSourceHeadlineSymbolCompany
12/07/202212:36InvestorsHub NewsWireOncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
29/06/202213:23InvestorsHub NewsWireOncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
08/06/202212:17InvestorsHub NewsWireOncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
09/05/202212:48InvestorsHub NewsWireOncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
13/04/202212:45InvestorsHub NewsWireOncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat CancerUSOTC:ONPHOncology Pharma Inc (CE)
02/03/202213:03InvestorsHub NewsWireOncology Pharma Reports on Progress with Ribera SolutionsUSOTC:ONPHOncology Pharma Inc (CE)
23/02/202213:00InvestorsHub NewsWireOncology Pharma Releases Further Feasibility Studies, Data and CapacitiesUSOTC:ONPHOncology Pharma Inc (CE)
17/02/202213:16InvestorsHub NewsWireOncology Pharma Expands on Feasibility Studies and DataUSOTC:ONPHOncology Pharma Inc (CE)
14/02/202213:11InvestorsHub NewsWireOncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer VaccineUSOTC:ONPHOncology Pharma Inc (CE)
08/02/202213:30InvestorsHub NewsWireOncology Pharma Gives Update on Technology, Formulation and Data CreationUSOTC:ONPHOncology Pharma Inc (CE)
10/01/202213:15InvestorsHub NewsWireOncology Pharma's New Year UpdateUSOTC:ONPHOncology Pharma Inc (CE)
17/12/202113:11InvestorsHub NewsWireOncology Pharma Meeting Towards Future DevelopmentsUSOTC:ONPHOncology Pharma Inc (CE)
09/12/202113:04InvestorsHub NewsWireOncology Pharma Year End Review and OutlookUSOTC:ONPHOncology Pharma Inc (CE)
30/11/202113:02InvestorsHub NewsWireOncology Pharma Research and VisionUSOTC:ONPHOncology Pharma Inc (CE)
08/11/202113:00InvestorsHub NewsWireOncology Pharma Reveals Plans for Development of Lead Cancer Drug CandidateUSOTC:ONPHOncology Pharma Inc (CE)
28/10/202115:11InvestorsHub NewsWireOncology Pharma, Inc. Gives Update on Ongoing Work and ProgressUSOTC:ONPHOncology Pharma Inc (CE)
16/10/202100:12StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
16/10/202100:12StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
16/10/202100:12StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
16/10/202100:12StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
15/10/202114:51InvestorsHub NewsWireOncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior ListingUSOTC:ONPHOncology Pharma Inc (CE)
12/10/202112:30InvestorsHub NewsWireOncology Pharma, Inc. Update on PCAOB Audit Selection Process and License AgreementUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
05/10/202100:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
17/09/202100:08StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35USOTC:ONPHOncology Pharma Inc (CE)
 Showing the most relevant articles for your search:USOTC:ONPH

Your Recent History

LSE
GDR
Genedrive
LSE
VAST
Vast Resources
LSE
SYME
Supply@me Capital
LSE
CPX
Cap-xx
LSE
BIRD
Blackbird
LSE
POS
Plexus
LSE
ITV
Itv
LSE
DEC
Diversified Energy
LSE
GKP
Gulf Keystone Petroleum
LSE
SBTX
Skinbiotherapeutics
LSE
AAZ
Anglo Asian Mining
LSE
DLG
Direct Line Insurance
LSE
GWMO
Great Western Mining
LSE
THG
Thg
LSE
TERN
Tern
LSE
BOO
Boohoo
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Gold Trader

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £3655.44 only £1827.72